Procurement Summary
Country : Ireland
Summary : Sole Supply of Medicines to the Hse
Deadline : 08 Mar 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 96165608
Document Ref. No. : 3036679
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
If any supplier considers itself to be a supplier of an alternative product to that included as a line item on the SSL, the supplier is requested to respond to this PMCand should do so by completing the attached response form (HSE 22316 Appendix 2 - Market Sounding Response Form) and reverting to the HSE via the eTenders messaging system.In the event that the marketplace reasonably demonstrates that any of the authorised medicinal products in the SSL can be commercially provided in the Republic of Ireland by an alternative supplier to that listed on the SSL, then that authorised medicinal product shall be removed from the SSL.The HSE considers that in the event the marketplace does not reasonably demonstrate that any of the authorised medicinal products in the SSL can be commercially provided by an alternative source in the Republic of Ireland, then the HSE may reasonably conclude that the exemptions available under Article 32 2 (b) may be employed for the procurement of such authorised medicinal products listed on the SSL.Suppliers who wish to inform the HSE of an authorised medicinal product which is marketed in the Republic of Ireland by a single source and has not been listed on the SSL should do so by completing response form (HSE 22316 Appendix 5 - Response for medicine additions or updates) and reverting to the HSE via the eTenders messaging system. Failure to complete response form in full, will result in requests not being actioned. . For the avoidance of doubt the HSE does not intend to employ Article 32 2 (b) for single source authorised medicinal products newly identified through this PMC. However, subject to verification by the HSE, any newly identified authorised medicinal products shall be included on the SSL for the next authorised medicinal products market engagement PMC planned for Q3 2024.** On 13/12/2019, the HSE published a PIN (OJEU ref: 2019/S 243-596458) seeking to establish a list of authorised medicinal products which were marketed in the R...
Procedure : Preliminary Market Consultation
Publication Date : 08/03/2024
Deadline : 08/03/2024 16:00:00
Documents
Tender Notice